Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dynacor Group Inc. announces preliminary fourth-quarter and full-year 2025 operating results and its 2026 outlook.
-
MCDONALD, Tenn., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTCQX: AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value refractory and titanium alloy...
-
AUSTIN, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SEON, the command center for real-time fraud prevention and AML compliance, delivered over 80% ARR growth in 2025 and added hundreds of new customers...
-
This announcement corrects a clerical error in the financial table, where “Q4 2025” should have read “Q4 2024.” Jyske Bank expects a net profit of c. DKK 5.4bn in 2025, corresponding to earnings per...
-
Jyske Bank forventer et resultat efter skat på ca. 5,4 mia. kr. i 2025, svarende til et resultat pr. aktie på ca. 85 kr. Tidligere var forventningerne et resultat efter skat i intervallet 4,9-5,3 mia....
-
Jyske Bank expects a net profit of c. DKK 5.4bn in 2025, corresponding to earnings per share of c. DKK 85. Previously, expectations were for a net profit of DKK 4.9bn-5.3bn, corresponding to earnings...
-
Fourth quarter 2025 total revenue expected to be approximately $11.3 million, representing growth of approximately 37% compared to the prior-year period.Received record multi-system order in the...
-
-- Q4 2025 preliminary net product revenues from global sales of IMCIVREE® (setmelanotide) of approximately $57 million for the fourth quarter of 2025, an 11% increase over Q3 2025 -- -- FY 2025...
-
Pandora today announced preliminary and unaudited results for 2025. The company is expected to deliver organic growth of 6% for 2025, marginally below the prior guidance of 7-8%. Group EBIT margin for...
-
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue of...